Patents Assigned to pHase Pharmaceuticals LLC
  • Sublingual epinephrine tablets
    Patent number: 12042472
    Abstract: The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
    Type: Grant
    Filed: January 13, 2022
    Date of Patent: July 23, 2024
    Assignee: pHase Pharmaceuticals LLC
    Inventors: G. Lynn Howard, Nicholas J. Farina, Edward J. Walters, Christopher Howard
  • Sublingual epinephrine tablets
    Patent number: 11253488
    Abstract: The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: February 22, 2022
    Assignee: pHase Pharmaceuticals LLC
    Inventors: G. Lynn Howard, Nicholas J. Farina, Edward J. Walters, Christopher Howard